BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15642704)

  • 1. An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review.
    Lens MB; Newton-Bishop JA
    Ann Oncol; 2005 Mar; 16(3):460-5. PubMed ID: 15642704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of an association between non-Hodgkin's lymphoma and skin cancer.
    Adami J; Frisch M; Yuen J; Glimelius B; Melbye M
    BMJ; 1995 Jun; 310(6993):1491-5. PubMed ID: 7787593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Melanoma, Hodgkin's Lymphoma and non-Hodgkin's Lymphoma: Common Risk Factors?
    Allam MF; Serrano PF; Serrano JL; Abd Elaziz KM; Del Castillo AS; Navajas RF
    Cent Eur J Public Health; 2015 Jun; 23(2):119-21. PubMed ID: 26851421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skin cancer and non-Hodgkin's lymphoma as second malignancies. markers of impaired immune function?
    Hemminki K; Jiang Y; Steineck G
    Eur J Cancer; 2003 Jan; 39(2):223-9. PubMed ID: 12509955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-melanoma skin cancer may be a marker of poor prognosis in patients with non-Hodgkin's lymphoma.
    Hjalgrim H; Frisch M; Storm HH; Glimelius B; Pedersen JB; Melbye M
    Int J Cancer; 2000 Mar; 85(5):639-42. PubMed ID: 10699942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients.
    Crocetti E; Carli P
    Eur J Cancer Prev; 2004 Feb; 13(1):33-7. PubMed ID: 15075786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
    Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
    Ann Oncol; 2007 Feb; 18(2):288-92. PubMed ID: 17088328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
    Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
    Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: composite (threefold) case-control study.
    Freedman DM; Zahm SH; Dosemeci M
    BMJ; 1997 May; 314(7092):1451-5. PubMed ID: 9167561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous T-cell lymphoma is associated with increased risk of lymphoma, melanoma, lung cancer, and bladder cancer.
    Goyal A; O'Leary D; Goyal K; Patel K; Pearson D; Janakiram M
    J Am Acad Dermatol; 2021 Dec; 85(6):1418-1428. PubMed ID: 32822803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin as the primary site of Hodgkin's disease: a case report of primary cutaneous Hodgkin's disease and review of its relationship with non-Hodgkin's lymphoma.
    Guitart J; Fretzin D
    Am J Dermatopathol; 1998 Apr; 20(2):218-22. PubMed ID: 9557796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Hodgkin's lymphoma after primary Hodgkin's disease in the German Hodgkin's Lymphoma Study Group: incidence, treatment, and prognosis.
    Rueffer U; Josting A; Franklin J; May M; Sieber M; Breuer K; Engert A; Diehl V;
    J Clin Oncol; 2001 Apr; 19(7):2026-32. PubMed ID: 11310450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hodgkin's disease, follicular non-Hodgkin's lymphoma and a high grade B cell non-Hodgkin's lymphoma in the same patient.
    Gibbs SJ; Tobias JS
    Leuk Lymphoma; 1995 Jun; 18(1-2):185-7. PubMed ID: 8580824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus associated with the occurrence and prognosis of non-Hodgkin's lymphoma.
    Lin SY; Hsieh MS; Chen LS; Chiu YH; Yen AM; Chen TH
    Eur J Cancer Prev; 2007 Oct; 16(5):471-8. PubMed ID: 17923820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metastatic malignant melanoma in treated non-Hodgkin's lymphoma].
    Falk S; Walther F; Denk R
    Hautarzt; 1996 Sep; 47(9):716-8. PubMed ID: 8999030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between malignant melanoma and noncutaneous malignancies.
    Wu YH; Kim GH; Wagner JD; Hood AF; Chuang TY
    Int J Dermatol; 2006 May; 45(5):529-34. PubMed ID: 16700785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second cancers in patients with brain tumours--impact of treatment.
    Salminen E; Pukkala E; Teppo L
    Eur J Cancer; 1999 Jan; 35(1):102-5. PubMed ID: 10211096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia.
    Brennan P; Coates M; Armstrong B; Colin D; Boffetta P
    Br J Cancer; 2000 Apr; 82(7):1344-7. PubMed ID: 10755412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
    Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
    Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.